 | • レポートコード：TPM-NV104 • 出版社/出版日：Transparency Market Research / 2019年8月16日 • レポート形態：英文、PDF、163ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、デジタル用量吸入器の世界市場について調べ、デジタル用量吸入器の世界市場規模、市場動向、市場シェア、市場環境、市場予測、製品別（定量吸入器および乾燥粉末吸入器）分析、用途別（喘息、COPD（慢性閉塞性肺疾患）、その他）分析、関連企業情報などをまとめました。 ・デジタル用量吸入器の市場概要 ・デジタル用量吸入器の市場動向 ・デジタル用量吸入器の世界市場規模・予測 ・デジタル用量吸入器市場：製品別（定量吸入器および乾燥粉末吸入器） ・デジタル用量吸入器市場：用途別（喘息、COPD（慢性閉塞性肺疾患）、その他） ・地域別分析（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争環境・関連企業分析 |
TMR’s recent publication on the digital dose inhalers market provides readers with an overview of the market, with the help of a detailed assessment of the global market scenario. The TMR study on the digital dose inhalers market evaluates the industry with respect to the historical and current market condition, and offers a forecast for the period of 2019-2027. Report audiences are able to make important decisions concerning their businesses with the help of the important findings and exclusive insights on the digital dose inhalers market. This TMR report is divided into different segments that allow readers to gain an individual understanding of the digital dose inhalers market.
Key Queries Addressed in the Report
How much revenue is the digital dose inhalers market expected to generate by the end of the forecast period?
Which digital dose inhaler is likely to generate the highest revenue by 2027?
What are the crucial growth factors and market dynamics that are expected to drive the growth of the digital dose inhalers market in the coming decade?
Which geographies have the potential for profitable avenues for digital dose inhalers market competitors?
What are the key strategies incorporated by leading digital dose inhaler players in an attempt to expand their market presence?
The first section in TMR’s report on the digital dose inhalers market begins with a preface that includes the report scope, market segmentation, and research highlights. This section provides an overall understanding of the market elements, and enables readers to understand the important aspects covered in the study. Following this, the report includes the market dynamics that offer an understanding of the market drivers, restraints, and opportunities.
The next section includes an extensive segmentation analysis of the digital dose inhalers market. Its analysis includes the division of the digital dose inhalers market on the basis of key factors such as product, application, and region. Evaluation of the key segments in the digital dose inhalers market, year-on-year growth projections, and basis point share analysis collated in the report further helps readers identify promising areas for business expansions.
The TMR study on the digital dose inhalers market offers an assessment of the geographical landscape of the market. Individualized, country-wise, and segment-wise analysis in context to individual regions helps readers of the digital dose inhalers market report to weigh the potential of the market in different geographies. Supported by year-on-year growth projections, and global value and volume share, this section is a crucial part of the report on the digital dose inhalers market.
This report on the digital dose inhalers market offers a holistic competitive analysis with the details of prominent and emerging market players. This chapter throws light on the nature of the digital dose inhalers market in relation to the market share held by leading players along with other emerging companies. This chapter also features the key focus areas of digital dose inhalers market players. The competitive structure of key players in the digital dose inhalers market is also included in this report publication.
Research Methodology
The TMR study on the digital dose inhalers market is based on an elaborate investigation of the market, integrated with comprehensive primary and secondary research inputs. Detailed assessment of the digital dose inhalers market in terms of competitive landscape is supported by an individual-level examination of the different avenues related to the industry. An analysis of the historical and current global market for digital dose inhalers is presented, thus focusing on key market segments, major regions, market drivers, and other qualitative inputs, which help TMR’s analysts arrive at anticipated predictions and forecast analysis of the digital dose inhalers market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Digital Dose Inhalers Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Digital Dose Inhalers Market Analysis and Forecast, 2017–2027
4.4.1. Global Digital Dose Inhalers Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Technological Advancements
5.2. Key Industry Events (Mergers, Acquisitions, Product Launch, etc.)
5.3. Epidemiology of Respiratory Diseases, such as Asthma, COPD (Chronic Obstructive Pulmonary Disease),etc.
6. Global Digital Dose Inhalers Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Digital Dose Inhalers Market Value Forecast, by Product, 2017–2027
6.3.1. Metered Dose Inhalers
6.3.2. Dry Powder Inhalers
6.4. Global Digital Dose Inhalers Market Attractiveness, by Product
7. Global Digital Dose Inhalers Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Digital Dose Inhalers Market Value Forecast, by Application, 2017–2027
7.3.1. Asthma
7.3.2. COPD (Chronic Obstructive Pulmonary Disease)
7.3.3. Others
7.4. Global Digital Dose Inhalers Market Attractiveness, by Application
8. Global Digital Dose Inhalers Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Digital Dose Inhalers Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Digital Dose Inhalers Market Attractiveness, by Region
9. North America Digital Dose Inhalers Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Digital Dose Inhalers Market Value Forecast, by Product, 2017–2027
9.2.1. Metered Dose Inhalers
9.2.2. Dry Powder Inhalers
9.3. North America Digital Dose Inhalers Market Value Forecast, by Application, 2017–2027
9.3.1. Asthma
9.3.2. COPD (Chronic Obstructive Pulmonary Disease)
9.3.3. Others
9.4. North America Digital Dose Inhalers Market Value Forecast, by Country/Sub-region, 2017–2027
9.4.1. U.S.
9.4.2. Canada
9.5. North America Digital Dose Inhalers Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By Application
9.5.3. By Country/Sub-region
10. Europe Digital Dose Inhalers Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Europe Digital Dose Inhalers Market Value Forecast, by Product, 2017–2027
10.2.1. Metered Dose Inhalers
10.2.2. Dry Powder Inhalers
10.3. Europe Digital Dose Inhalers Market Value Forecast, by Application, 2017–2027
10.3.1. Asthma
10.3.2. COPD (Chronic Obstructive Pulmonary Disease)
10.3.3. Others
10.4. Europe Digital Dose Inhalers Market Value Forecast, by Country/Sub-region, 2017–2027
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Digital Dose Inhalers Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By Application
10.5.3. By Country/Sub-region
11. Asia Pacific Digital Dose Inhalers Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Asia Pacific Digital Dose Inhalers Market Value Forecast, by Product, 2017–2027
11.2.1. Metered Dose Inhalers
11.2.2. Dry Powder Inhalers
11.3. Asia Pacific Digital Dose Inhalers Market Value Forecast, by Application, 2017–2027
11.3.1. Asthma
11.3.2. COPD (Chronic Obstructive Pulmonary Disease)
11.3.3. Others
11.4. Asia Pacific Digital Dose Inhalers Market Value Forecast, by Country/Sub-region, 2017–2027
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Digital Dose Inhalers Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By Application
11.5.3. By Country/Sub-region
12. Latin America Digital Dose Inhalers Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Latin America Digital Dose Inhalers Market Value Forecast, by Product, 2017–2027
12.2.1. Metered Dose Inhalers
12.2.2. Dry Powder Inhalers
12.3. Latin America Digital Dose Inhalers Market Value Forecast, by Application, 2017–2027
12.3.1. Asthma
12.3.2. COPD (Chronic Obstructive Pulmonary Disease)
12.3.3. Others
12.4. Latin America Digital Dose Inhalers Market Value Forecast, by Country/Sub-region, 2017–2027
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Digital Dose Inhalers Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By Application
12.5.3. By Country/Sub-region
13. Middle East & Africa Digital Dose Inhalers Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Middle East & Africa Digital Dose Inhalers Market Value Forecast, by Product, 2017–2027
13.2.1. Metered Dose Inhalers
13.2.2. Dry Powder Inhalers
13.3. Middle East & Africa Digital Dose Inhalers Market Value Forecast, by Application, 2017–2027
13.3.1. Asthma
13.3.2. COPD (Chronic Obstructive Pulmonary Disease)
13.3.3. Others
13.4. Middle East & Africa Digital Dose Inhalers Market Value Forecast, by Country/Sub-region, 2017–2027
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Israel
13.4.4. Rest of Middle East & Africa
13.5. Middle East & Africa Digital Dose Inhalers Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By Application
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Market Share/Position Analysis By Company (2018)
14.3. Company Profiles
14.3.1. Novartis AG
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Company Financials
14.3.1.3. Growth Strategies
14.3.1.4. SWOT Analysis
14.3.2. AstraZeneca
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Company Financials
14.3.2.3. Growth Strategies
14.3.2.4. SWOT Analysis
14.3.3. Glenmark
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Company Financials
14.3.3.3. Growth Strategies
14.3.3.4. SWOT Analysis
14.3.4. GlaxoSmithKline plc.
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Company Financials
14.3.4.3. Growth Strategies
14.3.4.4. SWOT Analysis
14.3.5. Teva Pharmaceutical Industries Ltd
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Company Financials
14.3.5.3. Growth Strategies
14.3.5.4. SWOT Analysis
14.3.6. 3M
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Company Financials
14.3.6.3. Growth Strategies
14.3.6.4. SWOT Analysis
14.3.7. Sensirion AG Switzerland
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Company Financials
14.3.7.3. Growth Strategies
14.3.7.4. SWOT Analysis
14.3.8. AptarGroup, Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Company Financials
14.3.8.3. Growth Strategies
14.3.8.4. SWOT Analysis
14.3.9. Cipla Inc.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Company Financials
14.3.9.3. Growth Strategies
14.3.9.4. SWOT Analysis
14.3.10. H&T Presspart Manufacturing Ltd
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Company Financials
14.3.10.3. Growth Strategies
14.3.10.4. SWOT Analysis
Note: Financial details for companies that do not report this information in public domain might not be captured
List of TablesTable 01: Epidemiology of Respiratory Diseases, such as Asthma, COPD (Chronic Obstructive Pulmonary Disease),etc.
Table 02: Epidemiology of Respiratory Diseases, such as Asthma, COPD (Chronic Obstructive Pulmonary Disease),etc.
Table 03: Global Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 04: Global Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 05: Global Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 06: North America Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 07: North America Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 08: North America Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 09: Europe Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 10: Europe Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 11: Europe Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 12: Asia Pacific Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 13: Asia Pacific Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 14: Asia Pacific Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 15: Latin America Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 16: Latin America Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 17: Latin America Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 18: Middle East & Africa Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 19: Middle East & Africa Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 20: Middle East & Africa Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Application, 2017–2027